Journal of Cardiovascular Disease Research
Comparison of Efficacy and Safety of Metformin and Vildagliptin versus Metformin and Glimepiride in Patients of Type – 2 Diabetes Mellitus
Dr Uday kumar M and Dr B. Srilatha
JCDR. 2024: 13 -18
Abstract
Introduction: Diabetes mellitus is a complex chronic metabolic condition defined by persistent hyperglycemia caused by abnormalities in insulin activity and/or secretion. Metformin, the mainstay of diabetic treatment, is frequently made more successful when combined with additional medications like glimepiride or vildagliptin. The current study aimed to compare the efficacy and safety of vildagliptin-metformin combination to glimepiride-metformin combination.
» PDF